[Treatment of chronic hepatitis C with peginterferon alpha-2a and the factors influencing the effect of this treatment].
Jin
Gen-Di
GD
Clinical Virology Research Unit, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China.
Gong
Qi-Ming
QM
Mao
Hong-Ju
HJ
Xu
Dao-Zhen
DZ
Lu
Zhi-Meng
ZM
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a